News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
243,228 Results
Type
Article (5869)
Company Profile (20)
Press Release (237339)
Section
Business (87663)
Career Advice (470)
Deals (16480)
Drug Delivery (9)
Drug Development (21283)
Employer Resources (32)
FDA (4051)
Job Trends (4547)
News (129789)
Policy (8418)
Tag
Academia (336)
Alliances (16172)
Alzheimer's disease (298)
Approvals (4064)
Artificial intelligence (38)
Bankruptcy (106)
Best Places to Work (3389)
Biotechnology (28)
Breast cancer (61)
Cancer (419)
Career advice (400)
Cell therapy (92)
Clinical research (17675)
Collaboration (150)
Compensation (124)
COVID-19 (450)
C-suite (76)
Data (468)
Diabetes (37)
Diagnostics (2237)
Earnings (42220)
Employer resources (33)
Events (40132)
Executive appointments (264)
FDA (4257)
Funding (184)
Gene therapy (38)
GLP-1 (120)
Government (505)
Healthcare (5558)
Infectious disease (466)
Interviews (57)
IPO (8389)
Job creations (1257)
Job search strategy (365)
Layoffs (106)
Legal (2669)
Lung cancer (44)
Manufacturing (47)
Medical device (4280)
Medtech (4282)
Mergers & acquisitions (8273)
Metabolic disorders (106)
Neuroscience (384)
NextGen: Class of 2025 (1792)
Non-profit (793)
Northern California (759)
Obesity (48)
Opinion (31)
People (26244)
Phase I (5242)
Phase II (7811)
Phase III (6071)
Pipeline (362)
Postmarket research (658)
Preclinical (2063)
Press Release (67)
Radiopharmaceuticals (119)
Rare diseases (65)
Real estate (2011)
Regulatory (5591)
Research institute (347)
Resumes & cover letters (68)
Southern California (561)
Startups (1123)
United States (6189)
Vaccines (50)
Date
Today (4)
Last 7 days (188)
Last 30 days (801)
Last 365 days (11831)
2025 (1451)
2024 (12221)
2023 (14522)
2022 (20432)
2021 (21855)
2020 (19711)
2019 (14319)
2018 (11021)
2017 (10891)
2016 (10005)
2015 (13164)
2014 (10359)
2013 (8349)
2012 (9039)
2011 (9446)
2010 (9259)
Location
Africa (198)
Arizona (59)
Asia (12095)
Australia (1647)
California (1587)
Canada (941)
China (54)
Colorado (73)
Connecticut (84)
Europe (25773)
Florida (210)
Georgia (33)
Illinois (103)
Indiana (62)
Japan (60)
Maine (37)
Maryland (182)
Massachusetts (1314)
Michigan (98)
Minnesota (125)
New Jersey (568)
New York (435)
North Carolina (306)
Northern California (759)
Ohio (47)
Pennsylvania (315)
South America (305)
Southern California (561)
Tennessee (29)
Texas (219)
Utah (51)
Virginia (31)
Washington State (145)
243,228 Results for "genfit corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GENFIT Announces 2025 Financial Calendar
January 30, 2025
·
5 min read
Press Releases
GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
February 10, 2025
·
9 min read
FDA
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis
Ipsen and Genfit’s elafibranor will now be marketed as Iqirvo and is the first new medicine approved in nearly a decade for the treatment of the rare liver disease, according to the companies.
June 11, 2024
·
2 min read
·
Tristan Manalac
Press Releases
GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan
January 30, 2025
·
17 min read
Press Releases
GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
February 7, 2025
·
9 min read
Press Releases
GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024
November 14, 2024
·
14 min read
Genetown
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today detailed its presence at the EASL Congress™ 2024.
May 29, 2024
·
8 min read
Press Releases
GENFIT Reports Third Quarter 2024 Financial Information
November 8, 2024
·
6 min read
Genetown
GENFIT: May 22, 2024 Combined Shareholders Meeting Results
GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, announced the results of the Combined Shareholders Meeting which took place on May 22, 2024.
May 22, 2024
·
4 min read
Business
GENFIT Reports First Quarter 2024 Financial Information
GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, announced its cash position as of March 31, 2024 and revenues for the first three months of 2024.
May 14, 2024
·
6 min read
1 of 24,323
Next
